These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26518926)

  • 1. Nodular Arteriolar Hyalinosis as Histopathologic Hallmark of Calcineurin Inhibitor Nephrotoxicity: Does It Always Have the Same Meaning?
    Vázquez LC; González AP; Juega J; Hernández-Gallego A; López D; Cañas L; Bancu I; Bonet J; Lauzurica R
    Transplant Proc; 2015 Oct; 47(8):2357-60. PubMed ID: 26518926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is arteriolar vacuolization a predictor of calcineurin inhibitor nephrotoxicity?
    Horike K; Takeda A; Yamaguchi Y; Ogiyama Y; Yamauchi Y; Murata M; Kawaguchi T; Suzuki T; Otsuka Y; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
    Clin Transplant; 2011 Jul; 25 Suppl 23():23-7. PubMed ID: 21623910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altitude and arteriolar hyalinosis after kidney transplantation.
    Cippà PE; Grebe SO; Fehr T; Wüthrich RP; Mueller TF
    Nephrology (Carlton); 2016 Sep; 21(9):782-4. PubMed ID: 26823025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
    Yagisawa T; Omoto K; Shimizu T; Ishida H; Tanabe K
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():51-7. PubMed ID: 26031587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic impacts of everolimus introduction on kidney transplant recipients.
    Nakamura T; Ushigome H; Takata T; Nakao T; Harada S; Koshino K; Suzuki T; Ito T; Nobori S; Yoshimura N
    Transplant Proc; 2015 Apr; 47(3):630-4. PubMed ID: 25891700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
    Nankivell BJ; PʼNg CH; OʼConnell PJ; Chapman JR
    Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arteriolar lesions in renal transplant biopsies: prevalence, progression, and clinical significance.
    Bröcker V; Schubert V; Scheffner I; Schwarz A; Hiss M; Becker JU; Scherer R; Haller H; Kreipe HH; Mengel M; Gwinner W
    Am J Pathol; 2012 May; 180(5):1852-62. PubMed ID: 22464889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular biopsy test based on arteriolar under-hyalinosis reflects increased probability of rejection related to under-immunosuppression.
    Einecke G; Reeve J; Halloran PF
    Am J Transplant; 2018 Apr; 18(4):821-831. PubMed ID: 28985016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease after nonrenal solid organ transplantation: a histological assessment and utility of chronic allograft damage index scoring.
    Kubal C; Cockwell P; Gunson B; Jesky M; Hanvesakul R; Dronavalli V; Bonser RS; Neil D
    Transplantation; 2012 Feb; 93(4):406-11. PubMed ID: 22217532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant.
    Rivelli RF; Gonçalves RT; Leite M; Santos MA; Delgado AG; Cardoso LR; Takiya CM
    Nephrology (Carlton); 2015 Mar; 20(3):168-76. PubMed ID: 25404086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Results in Recipients of Late Conversion to a Calcineurin Inhibitor-Free Regimen with Everolimus After Kidney Transplantation.
    Iwahara N; Hotta K; Hirose T; Shinohara N
    Transplant Proc; 2023 May; 55(4):803-808. PubMed ID: 37147197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology.
    Stevens RB; Foster KW; Miles CD; Kalil AC; Florescu DF; Sandoz JP; Rigley TH; Malik T; Wrenshall LE
    PLoS One; 2015; 10(10):e0139247. PubMed ID: 26465152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of primary diabetic nephropathy on arteriolar hyalinosis lesions in patients following kidney transplantation.
    Yamakawa T; Kobayashi A; Yamamoto I; Kawaguchi T; Imasawa T; Aoyama H; Akutsu N; Maruyama M; Saigo K; Yokoo T; Kitamura H
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():70-75. PubMed ID: 29968417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
    Rabot N; Büchler M; Foucher Y; Moreau A; Debiais C; Machet MC; Kessler M; Morelon E; Thierry A; Legendre C; Rivalan J; Kamar N; Dantal J
    Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study on renal biopsy before and after long-term calcineurin inhibitors therapy: an insight for pathogenesis of its toxicity.
    Singh L; Singh G; Sharma A; Sinha A; Bagga A; Dinda AK
    Hum Pathol; 2015 Jan; 46(1):34-9. PubMed ID: 25449629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol biopsies in pediatric renal transplantation: a precious tool for clinical management.
    Zotta F; Guzzo I; Morolli F; Diomedi-Camassei F; Dello Strologo L
    Pediatr Nephrol; 2018 Nov; 33(11):2167-2175. PubMed ID: 29980849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcineurin inhibitor-free protocols: risks and benefits.
    Barbari AG; Stephan AG; Masri MA
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):1-23. PubMed ID: 17237886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Relevance of Arteriolar C4d Staining in Patients With Chronic-active Antibody-mediated Rejection: A Pilot Study.
    Snijders MLH; Sablik KA; van den Bosch TPP; Hesselink DA; Betjes MGH; Batal I; Clahsen-van Groningen MC
    Transplantation; 2020 May; 104(5):1085-1094. PubMed ID: 31517782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney donor age of 50 years or above is a risk factor for calcineurin inhibitor-induced nephrotoxicity.
    Takada Y; Tanabe T; Sasaki H; Tsujimoto T; Hotta K; Okada K; Shiono Y; Minami K; Tanaka H; Harada H
    Clin Transplant; 2024 Jan; 38(1):e15196. PubMed ID: 37975424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.